Glycomine
Signal active
Organization
Contact Information
Overview
Glycomine is early-stage biotech working on replacement therapies for rare diseases. There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. 95% of rare diseases have not one single FDA-approved treatment. Glycomine develops therapeutics for diseases that have no treatment options.
About
Industries
Biotechnology, Pharmaceutical, Therapeutics
Founded
2013
Employees
1-10
Headquarters locations
San Francisco, California, United States, North America
Social
Profile Resume
Glycomine headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $2.9B in funding across 36 round(s). With a team of 1-10 employees, Glycomine is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Glycomine, raised $12.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$80.0M
Details
3
Glycomine has raised a total of $80.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 33.0M | ||
| 2021 | Early Stage Venture | 35.0M | ||
| 2016 | Early Stage Venture | 12.0M |
Investors
Glycomine is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Glycomine | - | FUNDING ROUND - Glycomine | 12.0M |
| Sanderling Ventures | - | FUNDING ROUND - Sanderling Ventures | 12.0M |
| Glycomine | - | FUNDING ROUND - Glycomine | 12.0M |
| Mesa Verde Venture Partners | - | FUNDING ROUND - Mesa Verde Venture Partners | 12.0M |
Recent Activity
News
Mar 05, 2024
Business Wire - Glycomine Announces Encouraging Efficacy Data from Ongoing Phase 2 Clinical Study in PMM2-CDG
News
Mar 04, 2024
Business Wire - Glycomine Announces Encouraging Efficacy Data from Ongoing Phase 2 Clinical Study in PMM2-CDG
News
Sep 18, 2023
Clinical Trials Arena - Pipeline Moves: Advancement prospects plunge for ...
Funding Round
Jun 23, 2021
Glycomine raised $35000000 on 2021-06-23 in Series B
Funding Round
Aug 07, 2019
Glycomine raised $33000000 on 2019-08-07 in Series B
Funding Round
Nov 16, 2016
Glycomine raised $12000000 on 2016-11-16 in Series A